We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Patient Advocates Request Public Hearing to Examine Court-Ordered Drug Restrictions
Patient Advocates Request Public Hearing to Examine Court-Ordered Drug Restrictions
A group of hemophilia patients and activists petitioned the FDA to hold a public hearing on court-ordered drug restrictions after an intellectual property suit filed by Shire requested restricted access for the hemophilia medication Hemlibra (emicizumab-kxwh).